|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.6 TWD | +1.04% |
|
+0.46% | -9.92% |
| May. 06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Maxigen Biotech Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 511.98 million compared to TWD 457.69 million a year ago. Net income was TWD 87.67 million compared to TWD 63.31 million a year ago.
Basic earnings per share from continuing operations was TWD 1.1 compared to TWD 0.8273 a year ago. Diluted earnings per share from continuing operations was TWD 1.0909 compared to TWD 0.8273 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.92% | 120M | |
| -0.68% | 260B | |
| +19.72% | 20.77B | |
| 0.00% | 19.36B | |
| +15.62% | 12.64B | |
| -14.17% | 9.2B | |
| +10.20% | 5.98B | |
| -2.43% | 4.46B | |
| -13.55% | 3.99B | |
| -5.97% | 3.65B |
MAXIGEN BIOTECH INC. 
